Article
Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2.
The Journal of clinical investigation - 1 Sept 2005
Seemann Petra, Schwappacher Raphaela, Kjaer Klaus W, Krakow Deborah, Lehmann Katarina, Dawson Katherine, Stricker Sigmar, Pohl Jens, Plöger Frank, Staub Eike, Nickel Joachim, Sebald Walter, Knaus Petra, Mundlos Stefan
Abstract excerpt
Here we describe 2 mutations in growth and differentiation factor 5 (GDF5) that alter receptor-binding affinities. They cause brachydactyly type A2 (L441P) and symphalangism (R438L), conditions previously associated with mutations in the GDF5 receptor bone morphogenetic protein receptor type 1b (BMPR1B) and the BMP antagonist NOGGIN, respectively. We expressed the mutant proteins in limb bud micromass culture and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
